Recruiting

Erchonia EVRL Laser for Foot Pain Relief in Idiopathic Peripheral Neuropathy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Erchonia® EVRL™

Device
Who is being recruted

Nervous System Diseases+1

+ Neuritis

+ Neuromuscular Diseases

Over 22 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: May 2025
See protocol details

Summary

Principal SponsorErchonia Corporation
Study ContactTravis Sammons
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2025

Actual date on which the first participant was enrolled.

This clinical study is focused on testing a device called the Erchonia® EVRL™, which is designed to help relieve foot pain caused by idiopathic peripheral neuropathy. Idiopathic peripheral neuropathy is a condition where people experience pain in their feet due to unknown reasons. The goal is to see if this device, which is used at home, can effectively reduce foot pain for those dealing with this condition. This study is important because it explores a new way to manage pain without needing to go to a clinic, offering a convenient solution for individuals suffering from this type of neuropathy. Participants in the study will use the Erchonia® EVRL™ device themselves at home. They will administer the treatment by using the laser device as directed. The study observes how well the device works in providing temporary pain relief. There is no mention of specific risks or benefits in the description, but it implies that the device is non-invasive since it uses laser technology, which is often considered safe for home use. The study does not involve comparing the device to any other treatment, focusing only on the effects of the Erchonia® EVRL™.

Official TitleAn Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain
Principal SponsorErchonia Corporation
Study ContactTravis Sammons
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

32 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 22 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Nervous System DiseasesNeuritisNeuromuscular DiseasesPeripheral Nervous System Diseases

Criteria

8 inclusion criteria required to participate
Previously diagnosed with idiopathic peripheral neuropathy by a suitably qualified and licensed health professional within the past 6 months.

Over the age of 22 years of age

Able to read and write English

Constant feet pain on-going over at least the past 3 months

Show More Criteria

6 exclusion criteria prevent from participating
Diabetic, referred to as having hemoglobin A1c (HbA1C) of 6.5% or higher

Previously diagnosed with any definitive (i.e. not idiopathic) cause of peripheral neuropathy by a suitably qualified and licensed health professional within the past 6 months, such as diabetes, injury, infection, toxins and poisons, alcoholism, medications such as chemotherapy, autoimmune disorders, etc..

Pregnant or possibly pregnant, breastfeeding, or planning pregnancy during the intended course of study participation

Open wounds (sores, cuts, ulcers, etc.) on or around the treatment area on the feet

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
The Erchonia® EVRL™ is made up of (1) 635 nanometers red laser diode and (1) 405 nanometers violet laser diode mounted in a portable handheld device.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Franco & Co

Miramar, United StatesOpen Franco & Co in Google Maps
Recruiting
One Study Center
Erchonia EVRL Laser for Foot Pain Relief in Idiopathic Peripheral Neuropathy | PatLynk